Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity

Related articles

1. Fusion protein pan-sarbecovirus vaccines elicit broadly protective immune responses targeting Clade 1a, 1b, and 3 sarbecoviruses

   This article has 28 authors:

   1. Alyson Kelvin
   2. Matthew Rogers
   3. Zahed Katooni
   4. Eva-Maria Uhlemann
   5. Rachelle Buchanan
   6. Erin Scruten
   7. Anthony Yourkowski
   8. Jocelyne Lew
   9. Akarin Asavajaru
   10. Jill Van Kessel
   11. Paul Pennington
   12. Andrea Kroeker
   13. Cynthia Swan
   14. Rinku Patel
   15. Brittany Thivierge
   16. Willian Deck
   17. Ravendra Garg
   18. Glenn Hamonic
   19. Wolfgang Koster
   20. Tracy Prysliak
   21. Anne-Catherine Fluckiger
   22. Jasminka Bozic
   23. Andrew Van Kessel
   24. Volker Gerdts
   25. Qiang Liu
   26. Arinjay Banerjee
   27. Darryl Falzarano
   28. Trina Racine

2. A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Broad Cross-Protection Against Heterologous Strains

   This article has 10 authors:

   1. Jingjing Xu
   2. Ningning Fu
   3. Zimin Liu
   4. Mengli Chen
   5. Guijun Ma
   6. Hehai Li
   7. Jianghui Wang
   8. Bo Yin
   9. Zhen Zhang
   10. Feifei Diao

3. Novel Intranasal Replication-Deficient NS1ΔC Flu Vaccine Confers Protection from Divergent Influenza A and B Viruses in Mice

   This article has 9 authors:

   1. Daria Shamakova
   2. Marina A. Shuklina
   3. Nikita Yolshin
   4. Ekaterina Romanovskaya-Romanko
   5. Anna-Polina Shurygina
   6. Kira Kudrya
   7. Arman Muzhikyan
   8. Mariia V. Sergeeva
   9. Marina Stukova